BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• DiagnoCure Joins the OTCQX Marketplace and S&P Corporation Records Listing

  April 2, 2013

   · 

  3 min read
• Drug Development

  NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer

  April 2, 2013

   · 

  6 min read
• Business

  Atherotech Diagnostics Lab Adds Corgenix Medical Corporation AspirinWorks® Test for Aspirin Effect

  April 2, 2013

   · 

  1 min read
• MRI Interventions, Inc.’ ClearPoint System Used by Physicians in Laser Ablation Procedures for Patients with Epilepsy and Brain Tumor

  April 2, 2013

   · 

  7 min read
• Business

  TheraVida, Inc. and SK Chemicals Co. Ltd. Announce License Agreement for the Development and Commercialization of THVD-201 and THVD-202 for Overactive Bladder in South Korea

  April 2, 2013

   · 

  4 min read
• DiaGenic ASA: Extraordinary General Meeting

  April 2, 2013

   · 

  1 min read
• Pharm Country

  The Mikey Czech Foundation Contributes $500,000 to DIPG Research at Dana-Farber Cancer Institute - Harvard Medical School

  April 2, 2013

   · 

  5 min read
• Genetown

  Zalicus Inc. Granted Key Formulation Patent for Z160

  April 2, 2013

   · 

  1 min read
• BioCapital

  Rexahn Pharmaceuticals, Inc. to Present Data on the Mechanism of Action of RX-5902: a First-in-Class Inhibitor of p68 Helicase for the Treatment of Solid Tumors at American Association for Cancer Research Annual Meeting 2013

  April 2, 2013

   · 

  1 min read
• Pharm Country

  SkelRegen Continues to Gain Traction in Skeletal Tissue Regeneration

  April 2, 2013

   · 

  2 min read